Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer.

Authors:
Wu R; Oshi M; Asaoka M; Yan L; Benesch MGK and 6 more

Journal:
Ann Surg

Publication Year: 2023

DOI:
10.1097/SLA.0000000000005954

PMCID:
PMC10481934

PMID:
37318852

Journal Information

Full Title: Ann Surg

Abbreviation: Ann Surg

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data sets from each of the geo databases can be downloaded from the following sites and access numbers: [ https://www ncbi nlm nih gov/geo /gse96058/gse25066/gse163882/gse123845/gse20271]."

Code Sharing
Evidence found in paper:

"T.K. pathology faculty advisor for AstraZeneca. The remaining authors report no conflicts of interest."

Evidence found in paper:

"K.T. is supported by the National Institutes of Health; R37CA248018, R01CA250412, R01CA251545, R01EB029596, and the US Department of Defense BCRP; W81XWH-19-1-0674 and W81XWH-19-1-0111. Roswell Park Comprehensive Cancer Center is supported by the National Cancer Institute cancer center support grant P30CA016056. L.Y. is supported by National Cancer Institute (NCI) grant P30CA016056 involving the use of Roswell Park Comprehensive Cancer Center’s Pathology Network, Genomics, and Biomedical Data Science Shared Resources. K.T., M.O., M.N., T.I., T.K., R.W., and Y.M.: Conceptualization; K.T., M.O., and R.W.: Design; L.Y., M.A., and R.W: Acquisition of data and analysis; M.O., R.W., and T.K.: Original draft preparation; K.T., L.Y., M.A., M.O., M.B., R.W., and T.I.: Review and editing; K.T.: Supervision; K.T.: Project administration; I.E., K.T., and T.I: Funding acquisition."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025